Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James H Boone

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Gastroenterology Research and Practice|June 20, 2015
Fecal Lactoferrin: Reliable Biomarker for Intestinal Inflammation in Pediatric IBDStephan Buderus, James H Boone, Michael J Lentze
ACS Infectious Diseases|September 22, 2020
<i>Clostridioides difficile</i> Infection: The Challenge, Tests, and GuidelinesDavid M Lyerly, James H Boone, Robert J Carman, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 3, 2021
Clinical performance of the H. PYLORI QUIK CHEK™ and H. PYLORI CHEK™ assays, novel stool antigen tests for diagnosis of Helicobacter pyloriMagnus Halland, Rashidul Haque, Jost Langhorst, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2012
In vivo selection of rifamycin-resistant Clostridium difficile during rifaximin therapyRobert J Carman, James H Boone, Harish Grover, et al.
Microbiome|October 9, 2016
Rapid change of fecal microbiome and disappearance of Clostridium difficile in a colonized infant after transition from breast milk to cow milkManli Y Davis, Husen Zhang, Lera E Brannan, et al.
Microbial Pathogenesis|November 3, 2004
Inhibition of bovine macrophage and polymorphonuclear leukocyte superoxide anion production by Haemophilus somnusMichael D Howard, James H Boone, Virginia Buechner-Maxwell, et al.
Inflammatory Intestinal Diseases|October 1, 2020
Fecal Lactoferrin and Other Stool Markers during Normal Pregnancy and in Inflammatory Bowel Diseases: A Prospective Study and Review of the LiteratureJames M Gray, Kristin Knight, Vu Q Nguyen, et al.
Journal of Pediatric Gastroenterology and Nutrition|June 22, 2010
Utility of fecal lactoferrin in identifying Crohn disease activity in childrenMarian D Pfefferkorn, James H Boone, James T Nguyen, et al.
Journal of Pediatric Gastroenterology and Nutrition|April 26, 2016
Assessment of Fecal ASCA Measurement as a Biomarker of Crohn Disease in Pediatric PatientsVivian Tang, Clarissa Valim, Rajat Moman, et al.
Journal of Pediatric Gastroenterology and Nutrition|April 7, 2007
Fecal lactoferrin is a sensitive and specific marker of disease activity in children and young adults with inflammatory bowel diseaseThomas R Walker, Michelle L Land, Alex Kartashov, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Gastroenterology Research and Practice|June 20, 2015
Fecal Lactoferrin: Reliable Biomarker for Intestinal Inflammation in Pediatric IBDStephan Buderus, James H Boone, Michael J Lentze
ACS Infectious Diseases|September 22, 2020
<i>Clostridioides difficile</i> Infection: The Challenge, Tests, and GuidelinesDavid M Lyerly, James H Boone, Robert J Carman, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 3, 2021
Clinical performance of the H. PYLORI QUIK CHEK™ and H. PYLORI CHEK™ assays, novel stool antigen tests for diagnosis of Helicobacter pyloriMagnus Halland, Rashidul Haque, Jost Langhorst, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2012
In vivo selection of rifamycin-resistant Clostridium difficile during rifaximin therapyRobert J Carman, James H Boone, Harish Grover, et al.
Microbiome|October 9, 2016
Rapid change of fecal microbiome and disappearance of Clostridium difficile in a colonized infant after transition from breast milk to cow milkManli Y Davis, Husen Zhang, Lera E Brannan, et al.
Microbial Pathogenesis|November 3, 2004
Inhibition of bovine macrophage and polymorphonuclear leukocyte superoxide anion production by Haemophilus somnusMichael D Howard, James H Boone, Virginia Buechner-Maxwell, et al.
Inflammatory Intestinal Diseases|October 1, 2020
Fecal Lactoferrin and Other Stool Markers during Normal Pregnancy and in Inflammatory Bowel Diseases: A Prospective Study and Review of the LiteratureJames M Gray, Kristin Knight, Vu Q Nguyen, et al.
Journal of Pediatric Gastroenterology and Nutrition|June 22, 2010
Utility of fecal lactoferrin in identifying Crohn disease activity in childrenMarian D Pfefferkorn, James H Boone, James T Nguyen, et al.
Journal of Pediatric Gastroenterology and Nutrition|April 26, 2016
Assessment of Fecal ASCA Measurement as a Biomarker of Crohn Disease in Pediatric PatientsVivian Tang, Clarissa Valim, Rajat Moman, et al.
Journal of Pediatric Gastroenterology and Nutrition|April 7, 2007
Fecal lactoferrin is a sensitive and specific marker of disease activity in children and young adults with inflammatory bowel diseaseThomas R Walker, Michelle L Land, Alex Kartashov, et al.
Pageof 2